Current standards and future perspectives in adjuvant treatment for biliary tract cancers.

[1]  M. Nagino,et al.  Predictive performance of Blumgart T staging for perihilar cholangiocarcinoma in a Japanese center , 2020, Journal of hepato-biliary-pancreatic sciences.

[2]  J. V. van Hooft,et al.  Comparison of short- and long-term outcomes between anatomical subtypes of resected biliary tract cancer in a Western high-volume center. , 2020, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[3]  A. Lièvre,et al.  Radioembolization Plus Chemotherapy for First-line Treatment of Locally Advanced Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial. , 2020, JAMA oncology.

[4]  A. Zhu,et al.  ClarIDHy: A global, phase III, randomized, double-blind study of ivosidenib (IVO) vs placebo in patients with advanced cholangiocarcinoma (CC) with an isocitrate dehydrogenase 1 (IDH1) mutation , 2019, Annals of Oncology.

[5]  Tae Hyun Kim,et al.  Benefit of Adjuvant Chemoradiotherapy in Resected Gallbladder Carcinoma , 2019, Scientific Reports.

[6]  Shimul A. Shah,et al.  Screening high risk populations for cancer: Hepatobiliary , 2019, Journal of surgical oncology.

[7]  P. Manoharan,et al.  18F-fluorodeoxyglucose positron emission tomography (18FDG-PET) for patients with biliary tract cancer: Systematic review and meta-analysis. , 2019, Journal of hepatology.

[8]  M. Borad,et al.  Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers: A Phase 2 Clinical Trial. , 2019, JAMA oncology.

[9]  A. Lamarca,et al.  In the literature: June 2019 , 2019, ESMO Open.

[10]  J. Bridgewater,et al.  Advanced intrahepatic cholangiocarcinoma: post-hoc analysis of the ABC-01, -02 and -03 clinical trials. , 2019, Journal of the National Cancer Institute.

[11]  T. Luedde,et al.  Diagnostic and prognostic biomarkers in cholangiocarcinoma , 2019, Liver international : official journal of the International Association for the Study of the Liver.

[12]  D. Malka,et al.  Adjuvant capecitabine in biliary tract cancer: a standard option? , 2019, The Lancet. Oncology.

[13]  A. Forner,et al.  Clinical presentation, diagnosis and staging of cholangiocarcinoma , 2019, Liver international : official journal of the International Association for the Study of the Liver.

[14]  S. Maithel,et al.  Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  K. Boudjema,et al.  Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  M. Nagino,et al.  Surgery for perihilar cholangiocarcinoma from a viewpoint of age: Is it beneficial to octogenarians in an aging society? , 2018, Surgery.

[17]  M. Tanabe,et al.  Orotate phosphoribosyltransferase as a predictor of benefit from S‐1 adjuvant chemotherapy for cholangiocarcinoma patients , 2018, Journal of gastroenterology and hepatology.

[18]  H. Kamachi,et al.  Cytoplasmic CD133 expression correlates with histologic differentiation and is a significant prognostic factor in extrahepatic bile duct cancer and gallbladder cancer , 2018, Oncology letters.

[19]  A. Lamarca,et al.  Biliary Tract Cancer: State of the Art and potential role of DNA Damage Repair. , 2018, Cancer treatment reviews.

[20]  M. Choti,et al.  Improved Survival in Surgically Resected Distal Cholangiocarcinoma Treated with Adjuvant Therapy: a Propensity Score Matched Analysis , 2018, Journal of Gastrointestinal Surgery.

[21]  M. Nagino,et al.  Recurrence after curative‐intent resection of perihilar cholangiocarcinoma: analysis of a large cohort with a close postoperative follow‐up approach , 2018, Surgery.

[22]  Seung‐Mo Hong,et al.  Validation of the Eighth American Joint Committee on Cancer Staging System for Distal Bile Duct Carcinoma , 2018, Cancer research and treatment : official journal of Korean Cancer Association.

[23]  Jin‐Young Jang,et al.  The impact of perioperative CA19‐9 change on the survival and recurrence patterns after adjuvant chemoradiotherapy in resectable extrahepatic cholangiocarcinoma , 2018, Journal of surgical oncology.

[24]  M. Ando,et al.  Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer , 2018, The British journal of surgery.

[25]  P. Philip,et al.  Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  A. Ejaz,et al.  Impact of adjuvant chemotherapy on survival in patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis. , 2017, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[27]  A. Zhu,et al.  New Horizons for Precision Medicine in Biliary Tract Cancers. , 2017, Cancer discovery.

[28]  R. Higuchi,et al.  High‐grade dysplasia/carcinoma in situ of the bile duct margin in patients with surgically resected node‐negative perihilar cholangiocarcinoma is associated with poor survival: a retrospective study , 2017, Journal of hepato-biliary-pancreatic sciences.

[29]  Lipika Goyal,et al.  Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  T. Gruenberger,et al.  Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[31]  S. Sabnis,et al.  Laparoscopic radical cholecystectomy for suspected early gall bladder carcinoma: thinking beyond convention , 2016, Surgical Endoscopy.

[32]  K. Boberg,et al.  Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) , 2016, Nature Reviews Gastroenterology &Hepatology.

[33]  M. Isogai,et al.  Benefit of extended radical surgery for incidental gallbladder carcinoma , 2016, Surgery Today.

[34]  Joon-Oh Park,et al.  Is There a Role for Adjuvant Therapy in R0 Resected Gallbladder Cancer?: A Propensity Score-Matched Analysis , 2016, Cancer research and treatment : official journal of Korean Cancer Association.

[35]  T. Pawlik,et al.  Patterns and prognostic value of lymph node dissection for resected perihilar cholangiocarcinoma , 2016, Journal of gastroenterology and hepatology.

[36]  M. Nagino,et al.  Evaluation of inflammation-based prognostic scores in patients undergoing hepatobiliary resection for perihilar cholangiocarcinoma , 2016, Journal of Gastroenterology.

[37]  A. Scarpa,et al.  Intrahepatic, peri-hilar and distal cholangiocarcinoma: Three different locations of the same tumor or three different tumors? , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[38]  Charles R. Thomas,et al.  SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  L. Dawson,et al.  Outcome of Adjuvant Therapy in Biliary Tract Cancers , 2015, American journal of clinical oncology.

[40]  Charles R. Thomas,et al.  Evaluation of Adjuvant Radiation Therapy for Resected Gallbladder Carcinoma: A Multi-institutional Experience , 2015, Annals of Surgical Oncology.

[41]  D. Yoon,et al.  Surgery Alone Versus Surgery Followed by Chemotherapy and Radiotherapy in Resected Extrahepatic Bile Duct Cancer: Treatment Outcome Analysis of 336 Patients , 2015, Cancer research and treatment : official journal of Korean Cancer Association.

[42]  N. Kumari,et al.  Outcomes of Adjuvant Chemoradiation and Predictors of Survival After Extended Cholecystectomy in Gall Bladder Carcinoma: a Single Institution Experience from an Endemic Region , 2015, Journal of Gastrointestinal Cancer.

[43]  R. Gill,et al.  Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: A systematic review and pooled analysis , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[44]  A. Lamarca,et al.  Should Patients with Resected Bile Duct Cancer Receive an Adjuvant Treatment , 2014 .

[45]  T. Utsunomiya,et al.  Role of CD151 expression in gallbladder carcinoma. , 2014, Surgery.

[46]  S. Chapman,et al.  Does the extent of lymphadenectomy, number of lymph nodes, positive lymph node ratio and neutrophil–lymphocyte ratio impact surgical outcome of perihilar cholangiocarcinoma? , 2014, European journal of gastroenterology & hepatology.

[47]  R. Artigiani-Neto,et al.  EVALUATION OF P53, E-CADHERIN, COX-2, AND EGFR PROTEIN IMUNNOEXPRESSION ON PROGNOSTIC OF RESECTED GALLBLADDER CARCINOMA , 2014, Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery.

[48]  M. Büchler,et al.  Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  M. Nagino,et al.  Prognostic delineation of papillary cholangiocarcinoma based on the invasive proportion: a single-institution study with 184 patients. , 2014, Surgery.

[50]  B. Müller,et al.  Adjuvant chemoradiation for resected gallbladder cancer: Treatment strategies for one of the leading causes of cancer death in Chilean women. , 2013, Indian journal of cancer.

[51]  M. Nagino,et al.  Evolution of Surgical Treatment for Perihilar Cholangiocarcinoma: A Single-Center 34-Year Review of 574 Consecutive Resections , 2013, Annals of surgery.

[52]  S. Paterson-Brown,et al.  Defining a positive circumferential resection margin in oesophageal cancer and its implications for adjuvant treatment , 2013, The British journal of surgery.

[53]  Kui Wang,et al.  Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[54]  Yiqun Yan,et al.  Intrahepatic cholangiocarcinoma: a clinicopathologic study of 37 resected cases. , 2013, Hepato-gastroenterology.

[55]  Meng‐chao Wu,et al.  Analysis of the Relationships between Clinicopathologic Factors and Survival in Gallbladder Cancer following Surgical Resection with Curative Intent , 2012, PloS one.

[56]  A. Zhu,et al.  Adjuvant therapy for intrahepatic cholangiocarcinoma: the debate continues. , 2012, The oncologist.

[57]  R. Riechelmann,et al.  Poor evidence to standardize adjuvant treatment for patients with biliary tract cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[58]  M. Nagino,et al.  Hepatopancreatoduodenectomy for Cholangiocarcinoma: A Single-Center Review of 85 Consecutive Patients , 2012, Annals of surgery.

[59]  M. Büchler,et al.  Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial. , 2012, JAMA.

[60]  S. Curley,et al.  Neither Neoadjuvant nor Adjuvant Therapy Increases Survival After Biliary Tract Cancer Resection with Wide Negative Margins , 2012, Journal of Gastrointestinal Surgery.

[61]  J. Knox,et al.  Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[62]  A. Allal,et al.  Is adjuvant radiotherapy needed after curative resection of extrahepatic biliary tract cancers? A systematic review with a meta-analysis of observational studies. , 2012, Cancer treatment reviews.

[63]  Y. Bang,et al.  Postoperative chemoradiotherapy for gallbladder cancer , 2012, Strahlentherapie und Onkologie.

[64]  Y. Murakami,et al.  Adjuvant chemotherapy with gemcitabine and S-1 after surgical resection for advanced biliary carcinoma: outcomes and prognostic factors , 2012, Journal of hepato-biliary-pancreatic sciences.

[65]  Charles R. Thomas,et al.  Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[66]  M. Talamonti,et al.  Survival outcomes in resected extrahepatic cholangiocarcinoma: effect of adjuvant radiotherapy in a surveillance, epidemiology, and end results analysis. , 2011, International journal of radiation oncology, biology, physics.

[67]  F. Pruvot,et al.  Prognostic value of jaundice in patients with gallbladder cancer by the AFC-GBC-2009 study group. , 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[68]  N. Kokudo,et al.  Intrahepatic cholangiocarcinoma: analysis of 44 consecutive resected cases including 5 cases with repeat resections. , 2011, American journal of surgery.

[69]  T. Takada,et al.  New prognostic factor influencing long-term survival of patients with advanced gallbladder carcinoma. , 2010, Surgery.

[70]  M. Miyazaki,et al.  Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan , 2010, British Journal of Cancer.

[71]  S. Woo,et al.  Adjuvant chemoradiation therapy in gallbladder cancer , 2010, Journal of surgical oncology.

[72]  M. Nagino,et al.  Surgical treatment of hilar cholangiocarcinoma in the “new era”: the Nagoya University experience , 2010, Journal of hepato-biliary-pancreatic sciences.

[73]  M. Nagino,et al.  Hepatectomy With Simultaneous Resection of the Portal Vein and Hepatic Artery for Advanced Perihilar Cholangiocarcinoma: An Audit of 50 Consecutive Cases , 2010, Annals of surgery.

[74]  K. Sung,et al.  Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience , 2010, Journal of hepato-biliary-pancreatic sciences.

[75]  D. Cunningham,et al.  Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. , 2010, The New England journal of medicine.

[76]  F. Giuliante,et al.  Liver resections for hilar cholangiocarcinoma. , 2010, European review for medical and pharmacological sciences.

[77]  G. Brandi,et al.  Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center , 2010, Journal of hepato-biliary-pancreatic sciences.

[78]  M. Aljiffry,et al.  Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009. , 2009, World journal of gastroenterology.

[79]  J. Donohue,et al.  Adjuvant therapy for gallbladder carcinoma: the Mayo Clinic Experience. , 2009, International journal of radiation oncology, biology, physics.

[80]  Jiefeng He,et al.  [Experience of surgical resection of Bismuth-Corlette type I and II hilar cholangiocarcinoma]. , 2009, Zhonghua wai ke za zhi [Chinese journal of surgery].

[81]  D. Low,et al.  Assessment of criteria and clinical significance of circumferential resection margins in esophageal cancer. , 2009, Archives of surgery.

[82]  J. Metz,et al.  Radiotherapy is associated with improved survival in adjuvant and palliative treatment of extrahepatic cholangiocarcinomas. , 2009, International journal of radiation oncology, biology, physics.

[83]  C. Anderson,et al.  Adjuvant therapy for resected extrahepatic cholangiocarcinoma: a review of the literature and future directions. , 2009, Cancer treatment reviews.

[84]  Y. Murakami,et al.  Gemcitabine-Based Adjuvant Chemotherapy Improves Survival After Aggressive Surgery for Hilar Cholangiocarcinoma , 2009, Journal of Gastrointestinal Surgery.

[85]  W. Hohenberger,et al.  Surgical Treatment of Mass-Forming Intrahepatic Cholangiocarcinoma: An 11-Year Western Single-Center Experience in 107 Patients , 2009, Annals of Surgical Oncology.

[86]  A. Benson,et al.  Treatment of unresectable cholangiocarcinoma using yttrium‐90 microspheres , 2008, Cancer.

[87]  M. Gonen,et al.  Extrahepatic cholangiocarcinoma: a comparison of patients with resected proximal and distal lesions. , 2008, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[88]  S. Curley,et al.  Extrahepatic Bile Duct Adenocarcinoma: Patients at High-Risk for Local Recurrence Treated with Surgery and Adjuvant Chemoradiation Have an Equivalent Overall Survival to Patients with Standard-Risk Treated with Surgery Alone , 2008, Annals of Surgical Oncology.

[89]  W. Scheithauer,et al.  Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study , 2008, British Journal of Cancer.

[90]  H. Nishio,et al.  Surgery for hilar cholangiocarcinoma: the Leeds experience. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[91]  Liu Yubin,et al.  Surgical Management and Prognostic Factors of Hilar Cholangiocarcinoma: Experience with 115 Cases in China , 2008, Annals of Surgical Oncology.

[92]  S. Choi,et al.  What prognostic factors are important for resected intrahepatic cholangiocarcinoma? , 2008, Journal of gastroenterology and hepatology.

[93]  Dean F Sittig,et al.  Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[94]  Charles M. Miller,et al.  Fifteen-year, single-center experience with the surgical management of intrahepatic cholangiocarcinoma: operative results and long-term outcome. , 2008, Surgery.

[95]  J. Ellenhorn,et al.  Adjuvant radiation therapy is associated with improved survival for gallbladder carcinoma with regional metastatic disease , 2007, Journal of surgical oncology.

[96]  Steven C Cunningham,et al.  Cholangiocarcinoma: Thirty-one-Year Experience With 564 Patients at a Single Institution , 2007, Annals of surgery.

[97]  M. Mihara,et al.  Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery , 2006, Journal of Gastroenterology.

[98]  D. Yoon,et al.  [Analysis of prognostic factors after curative resection for gallbladder carcinoma]. , 2006, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi.

[99]  V. Kapoor,et al.  Predictors of long-term survival in patients with gallbladder cancer , 2006, Journal of Gastrointestinal Surgery.

[100]  C. O'Suilleabhain,et al.  Management of hilar cholangiocarcinoma in the North of England: pathology, treatment, and outcome. , 2005, World journal of gastroenterology.

[101]  K. Campbell,et al.  Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinomad—part 3: Update on 5-year survival , 2005, Journal of Gastrointestinal Surgery.

[102]  Y. Jan,et al.  Clinicopathological Factors Predicting Long-term Overall Survival after Hepatectomy for Peripheral Cholangiocarcinoma , 2005, World Journal of Surgery.

[103]  R. Howard,et al.  Surgical Management of Hilar Cholangiocarcinoma , 2005, Annals of surgery.

[104]  H. Friess,et al.  Randomized clinical trial of pylorus‐preserving duodenopancreatectomy versus classical Whipple resection—long term results , 2005, The British journal of surgery.

[105]  M. Choti,et al.  Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution. , 2005, Journal of vascular and interventional radiology : JVIR.

[106]  M. Bloomston,et al.  Cholangiocarcinoma: Advocate an Aggressive Operative Approach with Adjuvant Chemotherapy , 2004, The American surgeon.

[107]  M. D'Angelica,et al.  Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma , 2003, Cancer.

[108]  C. Willett,et al.  Adjuvant external-beam radiotherapy with concurrent chemotherapy after resection of primary gallbladder carcinoma: a 23-year experience. , 2003, International journal of radiation oncology, biology, physics.

[109]  T. Takada,et al.  Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? , 2002, Cancer.

[110]  D. Heo,et al.  Role of postoperative radiotherapy in the management of extrahepatic bile duct cancer. , 2002, International journal of radiation oncology, biology, physics.

[111]  Michael J. Black,et al.  Improved survival in resected biliary malignancies. , 2002, Surgery.

[112]  M. Takada,et al.  Does radical resection improve the survival in patients with carcinoma of the gallbladder who are 75 years old and older? , 2002, World journal of surgery.

[113]  H. Kinoshita,et al.  Prognostic factors in patients with carcinoma of the papilla of Vater. , 2002, Hepato-gastroenterology.

[114]  K. Yamagiwa,et al.  Analysis of the relationships between clinicopathologic factors and survival time in intrahepatic cholangiocarcinoma. , 2002, American journal of surgery.

[115]  W. Jarnagin,et al.  Staging Laparoscopy in Patients With Extrahepatic Biliary Carcinoma: Analysis of 100 Patients , 2002, Annals of surgery.

[116]  H. Kinoshita,et al.  Macroscopic types of intrahepatic cholangiocarcinoma: clinicopathologic features and surgical outcomes. , 2002, Hepato-gastroenterology.

[117]  K. Hanazaki,et al.  Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis. , 2002, Hepato-gastroenterology.

[118]  H. Thomas,et al.  Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968–1998 , 2001, Gut.

[119]  T. Patel.  Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States , 2001, Hepatology.

[120]  W. Jarnagin,et al.  Gallbladder Cancer: Comparison of Patients Presenting Initially for Definitive Operation With Those Presenting After Prior Noncurative Intervention , 2000, Annals of surgery.

[121]  M. Büchler,et al.  Randomized prospective trial of pylorus-preserving vs. classic duodenopancreatectomy (whipple procedure): Initial clinical results , 2000, Journal of Gastrointestinal Surgery.

[122]  K. Lillemoe,et al.  Surgery for hilar cholangiocarcinoma: the Johns Hopkins approach. , 2000, Journal of hepato-biliary-pancreatic surgery.

[123]  K. Ohara,et al.  Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma. , 2000, International journal of radiation oncology, biology, physics.

[124]  D. Klimstra,et al.  Surgical treatment of 32 patients with peripheral intrahepatic cholangiocarcinoma , 1998, The British journal of surgery.

[125]  Katherine S. Virgo,et al.  Experience with distal bile duct cancers in U.S. Veterans Affairs hospitals: 1987–1991 , 1997, Journal of Surgical Oncology.

[126]  M. Brennan,et al.  Outcome of treatment for distal bile duct cancer , 1996, The British journal of surgery.

[127]  K. Hatakeyama,et al.  Outcome of radical surgery for carcinoma of the gallbladder according to the TNM stage. , 1996, Surgery.

[128]  K. Lillemoe,et al.  Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. , 1996, Annals of surgery.

[129]  C. Su,et al.  Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma. , 1996, Annals of surgery.

[130]  K. Lillemoe,et al.  Perihilar Cholangiocarcinoma Postoperative Radiotherapy Does Not Improve Survival , 1995, Annals of surgery.

[131]  J. Vauthey,et al.  Recent Advances in the Management of Cholangiocarcinomas , 1994, Seminars in liver disease.

[132]  J. Picus,et al.  Multidisciplinary treatment of biliary tract cancers , 1994, Journal of surgical oncology.

[133]  J. Piehler,et al.  Primary carcinoma of the gallbladder. , 1977, Archives of surgery.

[134]  Tamara Otzen,et al.  Extensión del tratamiento quirúrgico y quimioterapia adyuvante en pacientes con carcinoma incidental de la vesícula biliar , 2019, Cirugía y Cirujanos.

[135]  C. Manterola,et al.  Extension of surgical treatment and adjuvant chemotherapy in patients with incidental gallbladder cancer. , 2019, Cirugia y cirujanos.

[136]  Xiaonan Sun,et al.  Concurrent Chemoradiotherapy in Curatively Resected Gallbladder Carcinoma: A Propensity Score-Matched Analysis. , 2018, International journal of radiation oncology, biology, physics.

[137]  K. Akazawa,et al.  Comparison of Number Versus Ratio of Positive Lymph Nodes in the Assessment of Lymph Node Status in Extrahepatic Cholangiocarcinoma , 2015, Annals of Surgical Oncology.

[138]  T. Brunner,et al.  Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[139]  C. Willett,et al.  Concurrent chemoradiotherapy in resected extrahepatic cholangiocarcinoma. , 2009, International journal of radiation oncology, biology, physics.

[140]  N. Kondo,et al.  Diffuse Large B-cell Lymphoma in the Ampulla of Vater Causing Obstructive Jaundice: Report of a Case , 2007, Surgery Today.

[141]  S. Shiesh,et al.  The assessment of biliary CA 125, CA 19-9 and CEA in diagnosing cholangiocarcinoma--the influence of sampling time and hepatolithiasis. , 2002, Hepato-gastroenterology.

[142]  J. Donohue,et al.  Adjuvant external beam radiation therapy with concurrent chemotherapy in the management of gallbladder carcinoma. , 2002, International journal of radiation oncology, biology, physics.

[143]  D. Gouma,et al.  Role of radiotherapy, in particular intraluminal brachytherapy, in the treatment of proximal bile duct carcinoma. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[144]  Randall G. Lee,et al.  Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. , 1998, Annals of surgery.

[145]  A. Jain,et al.  Role of radiation therapy in carcinoma of the gall bladder--a preliminary indian experience. , 1996, Tropical gastroenterology : official journal of the Digestive Diseases Foundation.

[146]  P. Hermanek,et al.  Residual tumor (R) classification and prognosis. , 1994, Seminars in surgical oncology.

[147]  C. Sawyer,et al.  Primary carcinoma of the gallbladder. , 1956, American journal of surgery.